Curaleaf Holdings, Inc. is 1.1x more valuable than Definium Therapeutics, Inc. by market capitalization ($2.85 B vs $2.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CURLF | DFTX |
|---|---|---|
| Market cap | $2.85 B | $2.53 B |
| US-listed rank | #1848 | #1936 |
| Revenue (latest FY) | $1.27B | - |
| Net income (latest FY) | -$231.07M | -$183.79M |
| Net margin | -18.2% | - |
| SEC filings | 176 | 445 |
Curaleaf Holdings, Inc. is 1.1x more valuable than Definium Therapeutics, Inc. by market capitalization ($2.85 B vs $2.53 B).
Full pages: Curaleaf Holdings, Inc. and Definium Therapeutics, Inc., or browse the full rankings.